Changes in antioxidant status and biochemical indices after acute administration of artemether, artemether-lumefantrine and halofantrine in rats

Basic and Clinical Pharmacology and Toxicology

Volumn 102, Issue 4, 2008, Pages 412-418

  Adaramoye, Oluwatosin A ^a   Osaimoje, Dorcas O ^a   Akinsanya, Adewale M ^a   Nneji, Chiaka M ^a   Fafunso, Michael A ^a   Ademowo, Olusegun G ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CATALASE; CREATININE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HALOFANTRINE; SUPEROXIDE DISMUTASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; KIDNEY; LIPID PEROXIDATION; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; UREA NITROGEN BLOOD LEVEL;

ADMINISTRATION, ORAL; ALANINE TRANSAMINASE; ANIMALS; ANTIMALARIALS; ANTIOXIDANTS; ARTEMISININS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CATALASE; CREATININE; DRUG COMBINATIONS; ETHANOLAMINES; FLUORENES; GLUTATHIONE; GLUTATHIONE TRANSFERASE; INTUBATION, GASTROINTESTINAL; KIDNEY; LIPID PEROXIDATION; LIVER; MALE; PHENANTHRENES; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; TIME FACTORS;

ANIMALIA; RATTUS;

EID: 40849140893     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2008.00211.x     Document Type: Article

References (51)

1. Guinovart C, Navia MM, Tanner M, Alonso PL. Malaria: burden of disease. Curr Mol Med 2006 6 : 137 40.
2. World Health Organization (WHO). Implementation of the Global Malaria Control Strategy. Report of a WHO Study Group on the Implementation of the Global Plan of Action for Malaria Control 1993-2000, Geneva, WHO Technical Report Series, No. 839, 1993.
3. Philips RS. Current status of malaria and potentials for Control. Clin Microbiol Rev 2001 14 : 208 26.
4. http://who.int/cmc_upload/0/0/0//0/015/370/RBM/infosheet_3htm/ Roll Back Malaria (RBM), Malaria in Africa 2005.
5. Gallup J, Sachs J. The economic burden of Malaria. Am J Trop Med Hyg 2001 64 : 85 96.
6. Karbwang J, Na-Bangchang K, Wattanakoon Y, Thanavibul A, Harinasuta T. Artemether 5 versus 7 day regimen for severe falciparum malaria. Southeast Asian J Trop Med Public Health 1994 25 : 702 6.
7. Looareesuwan S, Wilairatana P, Chokejindachai W, Viriyavejakul P, Krudsood S, Singhasivanon P. Research on new antimalarial drugs and the use of drugs in combination at the Bangkok Hospital for Tropical Diseases. Southeast Asian J Trop Med Public Health 1998 29 : 344 54.
8. van Vugt M, Looareesuwan S, Wilairatana P et al. Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria. Trans R Soc Trop Med Hyg 2000 94 : 545 8.
9. von Seidlein L, Jaffar S, Pinder M et al. Treatment of African children with uncomplicated falciparum malaria with a new antimalarial drug, CGP 56697. J Infect Dis 1997 176 : 1113 6.
10. Nateghpour M, Ward SA, Howells RE. Development of halofantrine resistance and determination of cross-resistance patterns in Plasmodium falciparum. Antimicrob Agents Chemother 1993 37 : 2337 43.
11. Peters W. Drug resistance in malaria parasites of animals and man. Adv Parasitol 1998 41 : 1 62.
12. Brewer TG, Grate SJ, Peggins JO et al. Fatal neurotoxicity of arteether and artemether. Am J Trop Med Hyg 1994 51 : 251 9.
13. Genovese RF, Petras JM, Brewer TG. Arteether neurotoxicity in the absence of deficits in behavioural performance in rats. Ann Trop Med Parasitol 1995 89 : 447 9.
14. Schuster BG, Canfield CJ. Preclinical studies with halofantrine. Parasitol Today 1989 5 : 3 14.
15. Monlun E, Le-Metayer P, Szwandt S, Neau D, Longy-Boursier M, Horton J. Cardiac complications of halofantrine: a prospective study of 20 patients. Trans R Soc Trop Med Hyg 1995 89 : 430 3.
16. Horton J. Halofantrine in the treatment of malaria. Drug Saf 1995 13 : 271 2.
17. Mojon M, Wallon M, Gravey A, Peaud PY, Sartre J, Peyron F. Intravascular haemolysis following halofantrine intake. Trans R Soc Trop Med Hyg 1994 88 : 91.
18. Taylor WR, White NJ. Antimalarial drug toxicity: a review. Drug Saf 2004 27 : 25 61.
19. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951 193 : 265 75.
20. Rutkowski RB, Debaare L. An ultra-micro colorimetric method for determination of total and direct serum bilirubin. Clin Chem 1966 12 : 432 8.
21. Mohun AF, Cook IJY. Simple methods for measuring serum level of the glutamic oxaloacetic and glutamic pyruvic transaminases in routine laboratories. J Clin Pathol 1957 10 : 394 9.
22. Reitman S, Frankel S. A colorimetric method for the determination of serum level of glutamate-oxaloacetate and pyruvate transaminases. Am J Clin Pathol 1957 28 : 56 63.
23. Williamson T. A comparison between the phosphastrate and phenyl phosphate methods of alkaline phosphatase assay. Med Lab Technol 1972 29 : 182 7.
24. Jaffe M. Ueber den Neiderschlag, welchen Pikrinsäure im normalen harn Erzeught und über eine neue Reaction des Kreatinins. Z Physiol Chem 1886 10 : 391 400.
25. Talke H, Schubert GE. Enzymatische Harnstoff bestimmung in Blut and serum in Optischen Test nach Warburg. Klin Wochschr 1965 43 : 174.
26. McCord JM, Fridovich I. Superoxide dismutase, an enzymatic function for erythrocuperin. J Biol Chem 1969 244 : 6049 55.
27. Habig WH, Pabst MJ, Jakoby WB. Glutathione-S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974 249 : 7130 9.
28. Aebi H. Catalase estimation. In : Bergmeyer HV (ed.). Methods of Enzymatic Analysis. Verlag Chemic, New York, 1974 673 84.
29. Moron MA, Depierre JW, Mannervick B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochem Biophys Acta 1979 582 : 67 78.
30. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978 30 : 302 10.
31. Harris ED. Regulation of antioxidant enzymes. FASEB J 1992 6 : 2675 83.
32. De Feo P, Volpi E, Lucidi P et al. Chloroquine reduces whole body proteolysis in humans. Am J Physiol 1994 267 : E183 6.
33. Lew H, Quintanilha A. Effects of endurance training and exercise on tissue anti-oxidative capacity and acetaminophen detoxification. Eur J Drug Metab Pharmacokinet 1991 16 : 59 68.
34. Rajurkar RB, Khan ZH, Gujar GT. Studies on levels of Glutathione S-Transferase, its Isolation and Purification from Helicoverpa armingera. Curr Sci 2003 85 : 1355 60.
35. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Crit Rev Biochem Mol Biol 1995 30 : 445 600.
36. Adaramoye OA, Adeyemi EO. Hepatoprotection of D- galactosamine-induced toxicity in mice by purified fractions from Garcinia kola seeds. Basic Clin Pharmacol Toxicol 2006 98 : 135 41.
37. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979 59 : 527 605.
38. Bhattacharyya B, Chatterjee TK, Ghosh JJ. Effects of chloroquine on lysosomal enzymes, NADPH-induced lipid peroxidation, and antioxidant enzymes of rat retina. Biochem Pharmacol 1983 32 : 2965 8.
39. Ogunbayo OA, Adisa RA, Ademowo OG, Olorunsogo OO. Incidence of chloroquine induced oxidative stress in the blood of rabbit. Int J Pharmacol 2006 2 : 121 5.
40. Draper H, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1990 186B : 421 31.
41. Magwere T, Naik YS, Hasler JA. Effects of chloroquine treatment on antioxidant enzymes in rat liver and kidney. Free Radic Biol Med 1997 22 : 321 7.
42. Ogawa M. Present status and clinical therapy of pancreatic diseases. Nippon Naika Gakkai Zasshi 1992 10 : 1899 900.
43. Ogeturk M, Kus I, Colakoglu N, Zararsiz I, Ilhan N, Sarsilmaz M. Caffeic acid phenethyl ester protects kidneys against carbon tetrachloride toxicity in rats. J Ethnopharmacol 2005 97 : 273 80.
44. Pari L, Murugan P. Tetrahydrocurcumin: effect on chloroquine-mediated oxidative damage in rat kidney. Basic Clin Pharmacol Toxicol 2006 99 : 329 34.
45. Jens JJ, Hanne H. A Review on Liver Function Test. The Danish Hepatitis C 2002; website http://home3.inet.tele.dk/omni/hemochromatosis_iron.htm
46. Cornelius CE. Biochemical evaluation of hepatic function in dogs. J Am Anim Hosp Assoc 1979 15 : 25 9.
47. Vincent MP, Becquart JP, Receveur MC, Nordor O, Le-Bras M. Halofantrine overdosage. Presse Med 1992 21 : 131.
48. Obi E, Orisakwe OE, Asomugha LA, Udemezue OO, Orish VN. The hepatotoxic effect of halofantrine in guinea pigs. Indian J Pharmacol 2004 36 : 303 5.
49. Pari L, Amali RD. Protective role of tetrahydrocurcumin (THC) an active principle of turmeric on chloroquine induced hepatoxicity in rats. J Pharm Pharm Sci 2005 8 : 115 23.
50. Farombi EO, Olowu BI, Emerole GO. Effect of three structurally related antimalarial drugs on liver microsomal components and lipid peroxidation in rats. Comp Biochem Physiol 2000 126 : 217 24.
51. Debra KF, Megan NL. Quinine-induced hepatotoxicity. Ann Pharmacother 1999 33 : 32 4.